| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4489 | 142-72-3 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Feb. 1, 1979 | FDA | BAXTER HLTHCARE |
None
None
None
None
None
None
None
None
None
None
None
None
| ID | Source |
|---|---|
| 4018705 | VUID |
| N0000147013 | NUI |
| 16674-78-5 | SECONDARY_CAS_RN |
| 4018705 | VANDF |
| CHEBI:62964 | CHEBI |
| CHEMBL1200691 | ChEMBL_ID |
| CHEMBL3989858 | ChEMBL_ID |
| C000656591 | MESH_SUPPLEMENTAL_RECORD_UI |
| DB13996 | DRUGBANK_ID |
| 0E95JZY48K | UNII |
| DB09409 | DRUGBANK_ID |
| 314718 | RXNORM |
| NOCODE | MMSL |
| 007106 | NDDF |
| 008776 | NDDF |
| C0982266 | UMLSCUI |
| 8896 | PUBCHEM_CID |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| ProcalAmine | HUMAN PRESCRIPTION DRUG LABEL | 22 | 0264-1915 | INJECTION | 0.05 g | INTRAVENOUS | NDA | 24 sections |
| NORMOSOL-M AND DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 4 | 0990-7965 | INJECTION, SOLUTION | 21 mg | INTRAVENOUS | NDA | 14 sections |
| NORMOSOL-M AND DEXTROSE | HUMAN PRESCRIPTION DRUG LABEL | 4 | 0990-7965 | INJECTION, SOLUTION | 21 mg | INTRAVENOUS | NDA | 14 sections |